The report provides a detailed analysis essential for establishing a Nystatin production plant. It encompasses all critical aspects necessary for Nystatin production, including the cost of Nystatin production, Nystatin plant cost, Nystatin production costs, and the overall Nystatin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Nystatin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Nystatin is a polyene antifungal that treats superficial Candida infections, including oral thrush, oesophageal candidiasis, intestinal candidiasis, vaginal yeast infections, diaper rash, and cutaneous candidiasis. It is utilised as topical creams, oral suspensions, lozenges, or tablets that bind ergosterol in fungal membranes to form pores, causing cell leakage and death. Its oral forms prevent candidiasis in high-risk patients like immunocompromised individuals (AIDS, chemotherapy recipients), low birth-weight neonates, and denture-wearers.
Its topical applications manage skin and nail infections, excluding hyperkeratinized areas. It is also used as a lipid raft inhibitor in cellular biology, a perforated patch-clamp electrophysiology tool for ion-selective membrane pores, mould prevention on artworks, and veterinary prophylaxis against fungal overgrowth in animals.
The market for Nystatin is influenced by superficial fungal infections in immunocompromised patients. Its usage in neonates, diabetics, and elderly populations, along with affordable topical and oral formulations for candidiasis treatment and prophylaxis, boosts its demand. The North American region leads because of advanced healthcare and awareness, while the Asia-Pacific region expands rapidly with infrastructure development and population-driven demand.
The industrial Nystatin procurement is influenced by shortages from manufacturers, production delays for oral suspensions, and supply chain disruptions between brands and generics. Also, instability in price during transitions, which requires multi-supplier strategies, stockpiling, and regulatory monitoring, affects its sourcing further.
Raw Material for Nystatin Production
According to the Nystatin production plant project report, the key raw materials used in the production of Nystatin include Streptomyces noursei, glucose, and solvents.
Production Process of Nystatin
The extensive Nystatin production cost report consists of the following major industrial production process:
- By Fermentation: The production of Nystatin involves a fermentation process using Streptomyces noursei. The process starts with spore suspension inoculation into TSB(G) preculture medium. This incubates to grow biomass, then transfer inoculum to the production medium for the main fermentation, enabling biosynthesis of Nystatin. Finally, the product is extracted with DMF or DMSO to get pure Nystatin as the final product.
Nystatin appears as a yellow to light tan hygroscopic powder with a characteristic cereal-like odour. It has a molecular formula of C47H75NO17 and shows low solubility in water, methanol, and ethanol. It is insoluble in acetone, ether, and chloroform. It features a polyene macrolide structure with conjugated double bonds and a mycosamine sugar moiety. It has a low melting point around 44-46 degree Celsius and decomposition above 155 degree Celsius. It has moderate lipophilicity with a logP value of 0.5, and pKa values reflecting amphoteric properties. It remains unstable to air, light, heat, acids, and alkalis, forming pores in fungal membranes via ergosterol binding.
